ExpressPoints: Key Studies in Breast and Gynecologic Cancers

May 29-31, 2020; Online at meetings.asco.org/am
Download this short summary slideset of key takeaways from data on breast and gynecologic cancers presented at the 2020 ASCO Virtual Scientific Meeting.
Sara Hurvitz, MD, FACP
Bradley J. Monk, MD, FACS, FACOG
Format: Microsoft PowerPoint (.ppt)
File Size: 320 KB
Released: September 9, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
GlaxoSmithKline
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation

Related Content

Domenica Lorusso, MD, PhD, on the molecular reclassification of endometrial cancers and key ongoing immunotherapy trials, from Clinical Care Options (CCO)

Domenica Lorusso, MD, PhD Released: February 25, 2021

From Clinical Care Options (CCO), Webcast and downloadable slides reviewing the latest data on the use of PARP inhibitors to treat newly diagnosed advanced ovarian cancer

Prof Jonathan A. Ledermann, MD, FRCP, FMed Sci
Program Director
person default Alexandra Leary, MD, PhD person default Frederik Marmé, MD, PhD
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: February 19, 2021 Expired: February 18, 2022

Expert review and discussion of key data from SABCS 2020 in HER2-positive and hormone receptor–positive/HER2-negative disease, and metastatic triple-negative breast cancer from Clinical Care Options (CCO)

Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: February 19, 2021 Expired: February 18, 2022

On-demand Clinical Care Options (CCO) Webcast that reviews the latest clinical data informing the optimal management of patients with ovarian cancer from an expert global perspective.

Antonio Gonzalez-Martin, MD, PhD Ursula Matulonis, MD Prof Ignace Vergote Released: February 11, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue